Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,074 public trials 3,988 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.

NCT04915248

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • A.O. Spedali Civili di Brescia - Ematologia Brescia, Italy
  • Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia Milan, Italy
  • U.O. Ematologia AO di Padova Padova, Italy
  • Ematologia IRCCS Policlinico S. Matteo di Pavia Pavia, Italy
View all 18 locations
View Trial Details
Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Recruiting

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

NCT05557695

Conditions
Chronic Lymphocytic Leukemia, CLL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Research Site Aylesbury, United Kingdom
  • Research Site Bath, United Kingdom
  • Research Site Birmingham, United Kingdom
  • Research Site Bournemouth, United Kingdom
View all 29 locations
View Trial Details
Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

NCT06980480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Infirmary Health - Diagnostic & Medical Clinic (DMC) Mobile, Alabama, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • University of Kansas Westwood, Kansas, United States
  • University of Maryland | Greenebaum Cancer Center Baltimore, Maryland, United States
View all 56 locations
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

NCT05582993

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States
  • University of Iowa Hospitals & Clinics PARENT Iowa City, Iowa, United States
View all 23 locations
View Trial Details
Recruiting

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

NCT06546670

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Quotient Sciences Sea View Miami, Florida, United States
  • Boston Childrens Hospital Boston, Massachusetts, United States
  • East Carolina University Greenville, North Carolina, United States
View Trial Details
Recruiting

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

NCT07710248

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Pingdingshan First People's Hospital Pingdingshan, Henan, China
  • Jining No.1 People's Hospital Jining, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View all 22 locations
View Trial Details

Related conditions